CIK 0001357459
- Non-accelerated filer
- Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522007292
- Phone
- +1 858-704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Warrant (Right to Buy) | +40 | 40 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Warrant (Right to Buy) | +516 | 516 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Warrant (Right to Buy) | +27 | 27 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Warrant (Right to Buy) | +325 | 325 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Warrant (Right to Buy) | +293 | 293 | ||
| 2021-04-27 | Diaz Stephanie Director | Grant or award · Stock Option (Right to Buy) | +10,203 | 10,203 | ||
| 2021-04-27 | Diaz Stephanie Director | Grant or award · Stock Option (Right to Buy) | +4,406 | 4,406 | ||
| 2021-04-27 | Dawson Michael John Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +5,438 | 5,438 | ||
| 2021-04-27 | Dawson Michael John Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +20,391 | 20,391 | ||
| 2021-04-27 | Dawson Michael John Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +5,084 | 5,084 | ||
| 2021-04-27 | Dawson Michael John Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +1,962 | 1,962 | ||
| 2021-04-27 | Dawson Michael John Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +2,800 | 2,800 | ||
| 2021-04-01 | Mazzo David J Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2021-04-01 | GRAY MARY ANN Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2021-04-01 | Csimma Cristina Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2021-04-01 | Wei Binxian Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2020-04-03 | Wei Binxian Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2020-04-03 | Csimma Cristina Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2020-04-03 | GRAY MARY ANN Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2020-04-03 | Mazzo David J Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 |
Page 16 of 21 · 409 trades